Fund profile
AdBio Technologies (ex Advent France Biotechnology)
France
Leading
About
AdBio Partners, previously known as Advent France Biotechnology, is a Paris-based venture capital firm specializing in early-stage investments within the life sciences sector. Established in 2016, AdBio Partners focuses on identifying and nurturing promising startups across Europe, particularly in France, Belgium, Spain, and Ireland. Their investment strategy is centered on therapeutics, supporting innovative biotech projects with high potential to address unmet medical needs. The firm is deeply integrated into the European life sciences ecosystem, collaborating closely with research institutions and technology transfer offices to transform groundbreaking scientific discoveries into viable businesses. AdBio Partners also plays an active role in the development of its portfolio companies, often co-founding and providing hands-on operational support to ensure their growth and success. Led by an experienced team of professionals with extensive backgrounds in science, medicine, and entrepreneurship, AdBio Partners has successfully attracted international VC syndicates, further strengthening its portfolio. Some notable companies backed by AdBio include DiogenX and ARTHEx Biotech.
Details
Highlights
$12.1M
Historical average check
$100.8M
Historical max check
June 2024
Last investment date
23
Investments
Pharma
Biotech
Healthtech & Wellness
Data & Analytics
Hardware. Robotics & IoT
Showing 0 lists
Contacts
Lists that include this fund